课题基金 / 基金详情

Mechanisms of AID-dependent Adaptive and Innate Immunity

Mechanisms of AID-dependent Adaptive and Innate Immunity
AID 依赖性适应性和先天免疫机制
批准号:
8073885
负责人:
Reuben S Harris
金额:
$5.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-05-31

项目摘要

项目成果

Reuben S Harris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Immunoglobulin (Ig) gene diversification is required for an effective antibody response toward pathogens. A single protein, activation-induced deaminase (AID), triggers Ig gene diversification by the distinct processes of somatic hypermutation (SHM), class switch recombination (CSR) and, in some vertebrates, Ig gene conversion (IGC). Most evidence indicates that AID triggers these processes by deaminating Ig gene cytosines to uracils. Deamination within the expressed Ig gene variable regions can lead to SHM or IGC, and deamination within the Ig gene switch regions can lead to CSR. Differential processing of the resulting uracils is proposed to result in the distinct molecular outcomes of SHM, CSR or IGC. These observations raise several important questions: (i) how does the presence of uracils in DNA lead to the strand breaks required for IGC, CSR and possibly for SHM; (ii) how is AID specifically targeted to the Ig gene DNA (as opposed to any other cellular DNA); and (iii) does AID play a role in innate immunity by participating in the related DNA deamination-based mechanism of retroelement restriction? The first question will be answered by determining the genetic requirements for IGC and SHM in the vertebrate cell line DT40, which supports ongoing Ig gene diversification and can be readily manipulated. The answer(s) to the second question will be obtained through advanced proteomic methods to identify conserved AID-interacting proteins from DT40 and a human SHM-supporting cell line Ramos. The third question will be addressed by performing a comprehensive comparative analysis of the retroelement restriction abilities of AID proteins encoded by key branches of the vertebrate tree, from fish to humans. The fundamental studies proposed here will improve our understanding of the mechanisms of Ig gene diversification, the causes of human immunodeficiency syndromes and the origins of several B cell cancers. PROJECT NARRATIVE: Relevance to public health. Antibodies are a crucial part of our immune response to pathogens such as bacteria and viruses. At the DNA level, a single protein called AID helps to mold the antibody genes in such a way that a highly effective antibody response occurs. This proposal focuses on how AID is controlled and directed within an antibody-producing cell, and thereby this research will strengthen our understanding of the antibody response and the causes of some human antibody-associated diseases including cancers. PROJECT NARRATIVE Relevance to public health. Antibodies are a crucial part of our immune response to pathogens such as bacteria and viruses. At the DNA level, a single protein called AID helps to mold the antibody genes in such a way that a highly effective antibody response occurs. This proposal focuses on how AID is controlled and directed within an antibody-producing cell, and thereby this research will strengthen our understanding of the antibody response and the causes of some human antibody-associated diseases including cancers.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Modeling success and failure of Langmuir-Blodgett transfer of phospholipid bilayers to silicon dioxide.
模拟磷脂双层到二氧化硅的 Langmuir-Blodgett 转移的成功和失败。
DOI: 10.1016/s0006-3495(95)80309-7
发表时间: 1995
期刊: Biophysical journal
影响因子: 3.4
作者: [Osborn,TD, Yager,P]
通讯作者: Yager,P
Midwest AViDD Center
  • 批准号:
    10631659
  • 项目类别:
  • 资助金额:
    $45.68万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
Midwest AViDD Center
  • 批准号:
    10522804
  • 项目类别:
  • 资助金额:
    $6643.12万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
Administrative-Core-001
Project 3: Pandemic Virus Protease Inhibitors
  • 批准号:
    10522812
  • 项目类别:
  • 资助金额:
    $288.0万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
海外基金